About BIVIX
The Invenomic Fund Institutional Class is a mutual fund that pursues a long-short equity strategy, primarily focusing on U.S. equity markets. Its main objective is to deliver attractive risk-adjusted returns by investing in both long and short positions across a diversified range of stocks, with an emphasis on small-cap value companies. Managed by a team employing a fundamentally-driven and quantitatively-informed investment process, the fund leverages rigorous research to uncover opportunities on both sides of the market.
This institutional share class is designed for large investors, featuring a high minimum initial investment. Notable characteristics include a relatively high portfolio turnover and concentration in the top holdings, yet it maintains diversification across sectors such as technology, communication services, utilities, energy, and healthcare. The fund has demonstrated a track record of outperforming its category index over multi-year periods, underscoring its active approach and market significance in the alternative, long-short equity category.
With a higher expense ratio relative to peers, the Invenomic Fund Institutional Class appeals to sophisticated investors seeking exposure to both bullish and bearish market opportunities, playing a unique role in risk management and alpha generation within a diversified portfolio.
Fund Family Invenomic
Category Long-Short Equity
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol BIVIX
Share Class Institutional Class Shares
Index S&P Composite 1500 TR
BIVIX had a total return of -0.06% in the past year, including dividends.
Since the fund's inception, the average annual return has been 15.60%.
